Article info
Original Article
Adenosine triphosphate-based chemotherapy response assay predicts long-term survival of primary epithelial ovarian cancer
- Correspondence to Sang Wun Kim, Department of Obstetrics and Gynecology, Institute of Women’s Life Medical Science, Yonsei University College of Medicine, Seoul 03722, Republic of Korea; san1{at}yuhs.ac
Citation
Adenosine triphosphate-based chemotherapy response assay predicts long-term survival of primary epithelial ovarian cancer
Publication history
- Received August 30, 2018
- Revision received October 19, 2018
- Accepted October 22, 2018
- First published January 4, 2019.
Online issue publication
February 04, 2019
Article Versions
- Previous version (4 January 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2019. No commercial re-use. See rights and permissions. Published by BMJ.